CN103180304B - 噻唑烷二酮化合物的合成方法 - Google Patents
噻唑烷二酮化合物的合成方法 Download PDFInfo
- Publication number
- CN103180304B CN103180304B CN201180048949.3A CN201180048949A CN103180304B CN 103180304 B CN103180304 B CN 103180304B CN 201180048949 A CN201180048949 A CN 201180048949A CN 103180304 B CN103180304 B CN 103180304B
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- halogen
- alkyl
- alkoxyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 *CC(c1ccccc1)=O Chemical compound *CC(c1ccccc1)=O 0.000 description 18
- YSZMHMWTTFTSJW-VRPUZZSBSA-N C/C=C\C=C(/C)\C(COc1ccc(C)cc1)=O Chemical compound C/C=C\C=C(/C)\C(COc1ccc(C)cc1)=O YSZMHMWTTFTSJW-VRPUZZSBSA-N 0.000 description 1
- GXITUSCERRRNDI-UHFFFAOYSA-N C=C(C(N1)=O)SC1=O Chemical compound C=C(C(N1)=O)SC1=O GXITUSCERRRNDI-UHFFFAOYSA-N 0.000 description 1
- DCQINOJCUHTKDA-UHFFFAOYSA-N N=C(Cc1ccccc1)CS Chemical compound N=C(Cc1ccccc1)CS DCQINOJCUHTKDA-UHFFFAOYSA-N 0.000 description 1
- ZOBPZXTWZATXDG-UHFFFAOYSA-N O=C(CS1)NC1=O Chemical compound O=C(CS1)NC1=O ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
- C07C309/66—Methanesulfonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/141—Esters of phosphorous acids
- C07F9/145—Esters of phosphorous acids with hydroxyaryl compounds
Abstract
Description
Claims (54)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37228210P | 2010-08-10 | 2010-08-10 | |
US61/372,282 | 2010-08-10 | ||
PCT/US2011/047010 WO2012021476A1 (en) | 2010-08-10 | 2011-08-09 | Novel synthesis for thiazolidinedione compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103180304A CN103180304A (zh) | 2013-06-26 |
CN103180304B true CN103180304B (zh) | 2017-02-15 |
Family
ID=44511576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180048949.3A Active CN103180304B (zh) | 2010-08-10 | 2011-08-09 | 噻唑烷二酮化合物的合成方法 |
Country Status (15)
Country | Link |
---|---|
US (1) | US8933240B2 (zh) |
EP (1) | EP2603498B1 (zh) |
JP (1) | JP5927190B2 (zh) |
KR (2) | KR20130099034A (zh) |
CN (1) | CN103180304B (zh) |
AU (1) | AU2011289543C1 (zh) |
CA (1) | CA2807662C (zh) |
DK (1) | DK2603498T3 (zh) |
ES (1) | ES2609837T3 (zh) |
HU (1) | HUE031424T2 (zh) |
MX (1) | MX349006B (zh) |
NZ (1) | NZ606574A (zh) |
PL (1) | PL2603498T3 (zh) |
RU (1) | RU2593370C2 (zh) |
WO (1) | WO2012021476A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE030263T2 (en) | 2010-04-19 | 2017-04-28 | Octeta Therapeutics Llc | New synthesis for the preparation of thiazolidinedione compounds |
US8895748B2 (en) | 2010-08-10 | 2014-11-25 | Metabolic Solutions Development Company, Llc | Synthesis for thiazolidinedione compounds |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN85107870A (zh) * | 1984-10-03 | 1986-07-16 | 武田药品工业株式会社 | 噻唑烷二酮衍生物的制备方法和用途 |
CN1708486A (zh) * | 2002-10-08 | 2005-12-14 | 特拉科斯公司 | 二苯基乙烯化合物的新型杂环类似物 |
WO2009038681A1 (en) * | 2007-09-14 | 2009-03-26 | Metabolic Solutions Development Company | Thiazolidinedione analogues for the treatment of hypertension |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1766260A3 (ru) * | 1989-11-04 | 1992-09-30 | Пфайзер Инк (Фирма) | Способ получени производных тиазолидиндиона-2,4 или их фармацевтически приемлемых солей с щелочными металлами |
US5102904A (en) * | 1989-12-08 | 1992-04-07 | American Cyanamid Company | N-oxygenated arylpyrrole insecticidal, acaricidal and nematicidal agents and use thereas |
US5143930A (en) | 1990-02-07 | 1992-09-01 | Sankyo Company, Limited | Thiazolidine derivatives with anti-diabetic activity, their preparation and their use |
DK0579733T3 (da) | 1991-04-11 | 2001-10-15 | Upjohn Co | Thiazolidindionderivater, fremstilling og anvendelse deraf |
NO302471B1 (no) | 1991-12-26 | 1998-03-09 | Sankyo Co | Tiazolidinforbindelser og farmasöytisk preparat |
DE4304861A1 (en) * | 1992-02-20 | 1993-08-26 | Ciba Geigy Ag | Microbicidal compsns., esp. fungicides for plant protection - contg. new or known 2-amino-2-phenyl-ethyl-phosphonic acid cpds. |
SE9702305D0 (sv) | 1997-06-17 | 1997-06-17 | Astra Ab | New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives |
JPH1171358A (ja) * | 1997-06-20 | 1999-03-16 | Sankyo Co Ltd | 5−ベンジルチアゾリジン−2,4−ジオン誘導体の製法 |
AP869A (en) | 1998-01-05 | 2000-09-04 | Pfizer | 2,3-Substituted indole compounds as anti-inflammatory and analgesic agents. |
US6768008B2 (en) | 2000-04-24 | 2004-07-27 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
US20040087484A1 (en) | 2000-12-01 | 2004-05-06 | Sahota Pritam Singh | Combination of organic compounds |
WO2003029251A1 (en) | 2001-09-28 | 2003-04-10 | Biocon Limited | Novel process for the synthesis of thiazolidinedione derivatives |
JP2004300367A (ja) * | 2003-04-01 | 2004-10-28 | Toyo Ink Mfg Co Ltd | 光重合開始剤組成物 |
FR2861069B1 (fr) | 2003-10-17 | 2005-12-09 | Galderma Res & Dev | NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE |
US7645778B2 (en) * | 2005-01-19 | 2010-01-12 | Bristol-Myers Squibb Company | Heteroaryl compounds as P2Y1 receptor inhibitors |
PL2001468T3 (pl) | 2006-03-16 | 2013-03-29 | Metabolic Solutions Dev Co Llc | Analogi tiazolidynodionu |
PL2001469T3 (pl) | 2006-03-16 | 2012-10-31 | Metabolic Solutions Dev Co Llc | Analogi tiazolidynodionu |
WO2008118327A1 (en) | 2007-03-23 | 2008-10-02 | University Of Toledo | Conformationally restrained epothilone analogues as anti-leukemic agents |
WO2009148195A1 (en) | 2008-06-02 | 2009-12-10 | Daebong Ls, Ltd. | 5-(4-hydroxybenzyl)thiazolidine-2,4-dione as intermediate for synthesis of thiazolidinedione based compounds and process for preparing the same |
WO2010105048A1 (en) * | 2009-03-12 | 2010-09-16 | Metabolic Solutions Development Company | Thiazolidinedione analogues |
MX2012012094A (es) * | 2010-04-19 | 2012-12-17 | Metabolic Solutions Dev Co Llc | Sintesis novedosa para compuestos de tiazolidinadiona. |
HUE030263T2 (en) * | 2010-04-19 | 2017-04-28 | Octeta Therapeutics Llc | New synthesis for the preparation of thiazolidinedione compounds |
US8895748B2 (en) * | 2010-08-10 | 2014-11-25 | Metabolic Solutions Development Company, Llc | Synthesis for thiazolidinedione compounds |
-
2011
- 2011-08-09 MX MX2013001468A patent/MX349006B/es active IP Right Grant
- 2011-08-09 RU RU2013110310/04A patent/RU2593370C2/ru active
- 2011-08-09 CN CN201180048949.3A patent/CN103180304B/zh active Active
- 2011-08-09 PL PL11748830T patent/PL2603498T3/pl unknown
- 2011-08-09 NZ NZ606574A patent/NZ606574A/en unknown
- 2011-08-09 HU HUE11748830A patent/HUE031424T2/en unknown
- 2011-08-09 DK DK11748830.4T patent/DK2603498T3/en active
- 2011-08-09 EP EP11748830.4A patent/EP2603498B1/en active Active
- 2011-08-09 CA CA2807662A patent/CA2807662C/en active Active
- 2011-08-09 JP JP2013524158A patent/JP5927190B2/ja active Active
- 2011-08-09 US US13/813,516 patent/US8933240B2/en active Active
- 2011-08-09 KR KR1020137006022A patent/KR20130099034A/ko active IP Right Grant
- 2011-08-09 ES ES11748830.4T patent/ES2609837T3/es active Active
- 2011-08-09 WO PCT/US2011/047010 patent/WO2012021476A1/en active Application Filing
- 2011-08-09 KR KR1020197003682A patent/KR101988203B1/ko active IP Right Grant
- 2011-08-09 AU AU2011289543A patent/AU2011289543C1/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN85107870A (zh) * | 1984-10-03 | 1986-07-16 | 武田药品工业株式会社 | 噻唑烷二酮衍生物的制备方法和用途 |
CN1708486A (zh) * | 2002-10-08 | 2005-12-14 | 特拉科斯公司 | 二苯基乙烯化合物的新型杂环类似物 |
WO2009038681A1 (en) * | 2007-09-14 | 2009-03-26 | Metabolic Solutions Development Company | Thiazolidinedione analogues for the treatment of hypertension |
Non-Patent Citations (3)
Title |
---|
Effective‘non-aqueous hydrolysis’ of oximes with iodic acid in dichloromethane under mild,heterogeneous conditions;Sosale Chandrasekhar et. al.;《Tetrahedron Letters》;20021231;第43卷;第4023-4024页 * |
Quaternary Pilocarpine Derivatives as Potential Acetylcholine Antagonists. 2. Alterations in the Lactone and Imidazole Moieties;Avraham A. Ben-Bassat et. al.;《Journal of Medicinal Chemistry》;19760731;第19卷(第7期);第928-933页 * |
The Reaction of α-Halo Oximes with Triphenylphosphine. Formation of Imidoyl Bromide and of Oximinophosphonium Salts by a Novel Catalytic Effect of Bases;Mitsuo Masaki et. al.;《The Journal of Organic Chemistry》;19671130;第32卷(第11期);第3564-3568页 * |
Also Published As
Publication number | Publication date |
---|---|
US20130204008A1 (en) | 2013-08-08 |
CA2807662A1 (en) | 2012-02-16 |
WO2012021476A1 (en) | 2012-02-16 |
RU2593370C2 (ru) | 2016-08-10 |
AU2011289543C1 (en) | 2019-05-23 |
DK2603498T3 (en) | 2017-01-16 |
KR101988203B1 (ko) | 2019-06-11 |
MX349006B (es) | 2017-07-06 |
EP2603498A1 (en) | 2013-06-19 |
JP5927190B2 (ja) | 2016-06-01 |
JP2013535504A (ja) | 2013-09-12 |
AU2011289543B2 (en) | 2015-03-19 |
ES2609837T3 (es) | 2017-04-24 |
KR20190018027A (ko) | 2019-02-20 |
HUE031424T2 (en) | 2017-07-28 |
NZ606574A (en) | 2015-02-27 |
RU2013110310A (ru) | 2014-09-20 |
CN103180304A (zh) | 2013-06-26 |
CA2807662C (en) | 2019-10-08 |
MX2013001468A (es) | 2013-05-14 |
PL2603498T3 (pl) | 2017-06-30 |
US8933240B2 (en) | 2015-01-13 |
KR20130099034A (ko) | 2013-09-05 |
AU2011289543A1 (en) | 2013-02-21 |
EP2603498B1 (en) | 2016-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102029611B1 (ko) | 대사성 질환의 치료를 위한 ppar 절약형 티아졸리딘디온염 | |
JP5055268B2 (ja) | ヒストンデアセチラーゼの新規な阻害剤としての置換されたアミノプロペニルピペリジンまたはモルホリン誘導体 | |
JP5225076B2 (ja) | チアゾール環を含むカルボン酸誘導体の医薬用途 | |
AU2015365465B2 (en) | Amido thiadiazole derivatives as NADPH Oxidase inhibitors | |
AU2011333772B2 (en) | Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy | |
Taha et al. | Novel thiosemicarbazide–oxadiazole hybrids as unprecedented inhibitors of yeast α-glucosidase and in silico binding analysis | |
CN103153972A (zh) | 噻唑烷二酮化合物的新的合成方法 | |
WO2011007819A1 (ja) | ラクタムまたはベンゼンスルホンアミド化合物を含有する医薬 | |
AU2013283318B2 (en) | Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders | |
JP2003532730A (ja) | 細胞増殖抑制剤として有用な1,1−ジオキソイソチアゾリジンを持つインダゾール | |
US20040063775A1 (en) | Five-membered heterocyclic alkanoic acid derivative | |
WO2011094890A1 (en) | Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators | |
WO2001074771A1 (en) | Pyrrole-2,5-dione derivatives for the treatment of diabetes | |
DE102005005395A1 (de) | Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel | |
CN102947269B (zh) | 噻唑烷二酮化合物的新的合成方法 | |
CN103180304B (zh) | 噻唑烷二酮化合物的合成方法 | |
CN103153991B (zh) | 噻唑烷二酮化合物的合成方法 | |
Peng et al. | Design, synthesis, and evaluation of tricyclic compounds containing phenyl-tetrazole as XOR inhibitors | |
CN108484494A (zh) | 2-氧代-1,2-二氢吡啶-4-甲酸类化合物 | |
CN108368068A (zh) | 氨基唑衍生物 | |
CN112538071A (zh) | 用作raf-1抑制剂的化合物、制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1182099 Country of ref document: HK |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20161027 Address after: michigan Applicant after: Ake Tainta therapeutics Ltd Address before: michigan Applicant before: Metabolic Solutions Dev Co. LLC |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: michigan Patentee after: Siri Maher J therapy Limited by Share Ltd Address before: michigan Patentee before: Ake Tainta therapeutics Ltd |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1182099 Country of ref document: HK |